Home
Home
  • Home
  • About Us About Us
    • Overview
    • Who we are
    • Why we provide advice
    • What are health technologies
    • Meetings
    • News
    • Who we work with
    • Contact Us
  • What We Do What We Do
    • Overview
    • Our Strategy
    • Work programme
    • Range of advice products
    • Quarterly Bulletin of advice
    • Early HTA Advice Service
  • Our Advice
  • Request Advice Request Advice
    • Overview
    • Form for requesting advice
  • Get Involved Get Involved
    • Overview
    • Contribute to advice
    • NHS boards
    • Patient and Public Involvement
    • Industry Involvement
    • Observe a council meeting
    • DOI Form

Advice Statement

  • Home
  • Our Advice
  • Rapid antigen detection tests (RADTs) for group A Streptococcal (GAS) infection

Title

Output Type

Speciality

Published

Title

Rapid antigen detection tests (RADTs) for group A Streptococcal (GAS) infection

Output Type

Advice Statement

Speciality

Ear, nose and throat, Infectious disease

Published

17 August 2018

Recommendation for NHSScotland

A systematic review of three non-UK cluster randomised controlled trials (RCTs) reported that the use of rapid antigen detection tests (RADTs) reduces rates of antibiotic prescribing. The delayed prescribing strategy recommended as UK standard care may limit the applicability of these findings.

Based on one UK study in the context of delayed antibiotic prescribing, the use of a RADT for presence of Group A Streptococcal bacteria (GAS) in patients with acute sore throat in the general practice setting did not provide additional benefit in terms of symptom resolution or rates of antibiotic use when compared with use of a formal clinical scoring system.  In this study, use of RADTs was not cost effective.

NHSScotland is required to consider the Scottish Health Technologies Group (SHTG) advice.

What were we asked to look at?

We were asked to provide advice on the clinical and cost effectiveness of rapid antigen detection tests (RADTs) for Group A Streptococcal (GAS) infection in patients with acute sore throat in primary care, based on the published literature.

Why is this important?

Microbial resistance to antibiotics is a major public health issue. Improving the targeting of antibiotics to those patients who are most likely to benefit is one strategy for addressing this issue.

Referred by

NHS Borders and the Medicines Management Partnership

 

Download icon
Download Advice
pdf (286 KB)
Download icon
Download Plain Language Summary
pdf (133 KB)
Download icon
Download Evidence Note
pdf (344 KB)

Connect with Us

Please let us know if you'd like to receive regular updates on our work.


Last Updated: 31 January 2022

Scottish Health Technologies Group

© 2021, All rights reserved

  • Accessibility
  • Respecting your privacy
  • Cookies
  • Healthcare Improvement Scotland Website
  • Find us on Twitter
  • Freedom of Information

Tell us what you think


We'd love to hear your views

Was our advice useful?  Did you find what you were looking for on our website?